Company: CYTK
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013167
Chunk: 25

Company: CYTOKINETICS INC
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 25
---
 | Cytokinetics, Inc.|2025 Proxy Statement |

TABLE OF CONTENTS PROPOSAL TWO

Registration with the SEC If the amendment and restatement described in this Proposal 2 is approved by our stockholders, we will file a Registration Statement on Form S-8 with the SEC with respect to the shares of our Common Stock to be registered pursuant to the 2004 EIP, as so amended and restated, as soon a reasonably practicable following stockholder approval.

| THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTEFORTHIS PROPOSAL 2 TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S AMENDED AND RESTATED 2004 EQUITY INCENTIVE PLAN TO: (I) INCREASE THE NUMBER OF AUTHORIZED SHARES RESERVED FOR ISSUANCE THEREUNDER BY 5,000,000 SHARES OF COMMON STOCK AND PROVIDE FOR LIMITATIONS ON THE MAXIMUM GRANT VALUE THAT NON-EXECUTIVE DIRECTORS MAY RECEIVE UNDER SUCH PLAN OF $1,000,000 FOR ANNUAL GRANTS TO CONTINUING DIRECTORS AND (II) $1,250,000 FOR THE INITIAL GRANT TO NEW DIRECTORS. |

| Cytokinetics, Inc.|2025 Proxy Statement |     | 15 |

TABLE OF CONTENTS PROPOSAL THREE Approval of Amendment to the Company’s Amended and Restated Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock Available for Issuance by the Company from 163,000,000 to 326,000,000 Shares of Common Stock Proposal On February 11, 2025, our Board of Directors approved the adoption of, and declared advisable to the Company and its stockholders, subject to stockholder approval, a proposed certificate of amendment to the Company’s Amended and Restated Certificate of Incorporation substantially in the form attached as Appendix B hereto (the “Restated Certificate”) to increase the number of authorized shares of Common Stock from 163,000,000 shares to 326,000,000 shares. Purpose and Effect of the Proposal Our Board of Directors believes it is in the best interest of the Company and its stockholders to increase the number of authorized shares of Common Stock to give the Company greater flexibility in considering and planning for future potential business needs. Having the additional authorized shares available is important to our continued efforts to pursue our strategic goals. Other than with respect to sales that may be made under the Sales Agreement with Jefferies